ZyVersa Therapeutics Revenue

Pharmaceutical Manufacturing • Weston, Florida, United States • 11-20 Employees

ZyVersa Therapeutics revenue & valuation

Annual revenue	$1,026,660
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$3,300,000
Total funding	$15,700,000

Key Contacts at ZyVersa Therapeutics

Steve Glover

Co-Founder, Chairman And Chief Executive Officer

Steve Glover

Chief Executive Officer

Company overview

Headquarters	2200 N. Commerce Parkway, Suite 208, Weston, FL 33326, US
Phone number	+17542311688
Website	zyversa.com
NAICS	3254
SIC	283
Keywords	Nephrology, Drug Development, Immunology, Orphan Disease
Founded	2014
Employees	11-20
Socials

ZyVersa Therapeutics Email Formats

ZyVersa Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@zyversa.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@zyversa.com	100%

About ZyVersa Therapeutics

ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging two licensed proprietary product platforms to develop pharmaceutical products that address unmet medical needs in the areas of renal and inflammatory diseases. Lead renal candidate, Phase 2a-ready VAR 200, mediates removal of excess intracellular lipids in the kidney’s filtration system that contribute to kidney damage leading to end-stage kidney disease. Lead anti-inflammatory drug candidate, inflammasome ASC inhibitor (IC 100), blocks initiation and perpetuation of damaging inflammation that’s pathogenic in a multitude of inflammatory diseases.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Manager

Founder/Owner

Employees by Department

ZyVersa Therapeutics has 8 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore ZyVersa Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-05-26	14	$11,000,000
2024-03-19	14	$2,700,000
2025-04-06	14	$2,000,000

Funding Insights

$15,700,000

Total funding amount

$2,000,000

Most recent funding amount

Number of funding rounds

ZyVersa Therapeutics Tech Stack

Discover the technologies and tools that power ZyVersa Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Apache HTTP Server

Web servers

Retina.js

JavaScript libraries

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

GoDaddy

Hosting

Font Awesome

Font scripts

FancyBox

JavaScript libraries

Bootstrap

UI frameworks

jQuery UI

JavaScript libraries

Google Analytics

Analytics

cdnjs

CDN

Frequently asked questions

ZyVersa Therapeutics is located in Weston, Florida, US.

You can reach ZyVersa Therapeutics at +17542311688.

ZyVersa Therapeutics generates an estimated annual revenue of $1,026,660. This revenue figure reflects the company's market position and business performance in its industry.

ZyVersa Therapeutics has an estimated valuation of $3,300,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ZyVersa Therapeutics was founded in 2014, making it 12 years old. The company has established itself as a significant player in its industry over this time.

ZyVersa Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

ZyVersa Therapeutics has raised a total of $15,700,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at ZyVersa Therapeutics

Steve Glover

Co-Founder, Chairman And Chief Executive Officer

Steve Glover

Chief Executive Officer

4.8

40,000 users